Skip Navigation

Europace 2000 2(4):304-311; doi:10.1053/eupc.2000.0118
© 2000 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Sisti, A.
Right arrow Articles by Leclercq, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Sisti, A.
Right arrow Articles by Leclercq, J.-F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


ATRIAL ARRHYTHMIAS

Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing

A. De Sisti, P. Attuel, S. Manot, P. Fiorello, F. Halimi and J.-F. Leclercq

Centre Chirurgical Val D'Or Saint-Cloud, France

Abstract

AIMS: The effectiveness of atrial pacing in reducing the incidence of atrial fibrillation in patients with sinus node dysfunction is incomplete, and the correlation between electrophysiological atrial properties and the effect of permanent atrial pacing has been poorly investigated. Accordingly, the aim of the present study was to correlate electrophysiological data, in terms of atrial refractoriness, conduction parameters, and propensity to atrial fibrillation induction, and the likelihood of atrial fibrillation after DDD device implantation.

METHODS AND RESULTS: The authors reviewed electrophysiological data of 41 patients with sinus node dysfunction (mean age 70±8 years, who were investigated free of antiarrhythmic treatments before pacemaker implantation. At a drive cycle length of 600 ms, effective and functional refractory periods, S1–A1 and S2–A2 latency, A1 and A2 width, and latent vulnerability index (effective refractory period [ERP] A2), were measured. Atrial fibrillation induction was tested with up to three extrastimuli in 34 patients. Induction of sustained atrial fibrillation (>1 min) was considered as the end-point. P-wave duration on the surface ECG in lead II/V1 was also measured. Minimal atrial rate was programmed between 60 and 75 bpm (mean: 64±4 bpm). After implantation, the patients were followed-up for 28±17 months, and ECG-documented occurrence of atrial fibrillation was determined. Electrophysiological characteristics of patients with (n=12) or without (n=29) paroxysmal atrial fibrillation before implantation were similar. When comparing patients with (n=11) or without (n=30) post-pacing atrial fibrillation occurrence, no differences were found in age, underlying heart disease, left atrial size, minimal pacing rate, and follow-up duration. Additionally, between the two former groups, there was no significant difference in terms of effective refractory periods (233±47 ms vs 239±25 ms), functional refractory periods (280±48 ms vs 272±21 ms), S1–A1 (44±20 ms vs 37±13 ms) and S2–A2 latency (77±28 ms vs 66±22 ms), and A1 duration (60±23 ms vs 53±16 ms). In contrast, in patients with post-pacing atrial fibrillation occurrence, the P wave was more prolonged (116±22 ms vs 98±13 ms;P< 0·01), A2 was longer (116±41 ms vs 87±27 ms;P< 0·01), effective refractory periods/A2 was lower (2·1±0·4 cm vs 3·1±1·4 cm;P< 0·05), and rate of atrial fibrillation induction was higher (8/11 patients vs 8/23 patients;P< 0·05). Electrophysiological characteristics of patients free of post-pacing atrial fibrillation with associated (n=6) or unassociated (n=24) paroxysmal atrial fibrillation history before implantation were quite similar. In patients with post-pacing atrial fibrillation with associated (n=6) or unassociated atrial fibrillation history (n=5) before implantation, effective refractory periods was statistically different (207±23 ms vs 264±46 ms;P< 0·05). Values of effective refractory periods <220 ms were significantly more frequent in patients with post-pacing atrial fibrillation than in patients without (4/11 patients vs 2/30 patients;P< 0·05). When comparing patients with post-pacing atrial fibrillation with effective refractory periods ≥220 ms (n=7) and <220 ms (n=4), A2 duration was remarkably prolonged (145±42 ms vs 90±11 ms;P< 0·05) in those with effective refractory periods ≥220 ms. By contrast, between the two groups, effective refractory periods/A2 were identical (2·08±0·6 cm vs 2·15±0·3 cm;P=n.s.).

CONCLUSION: Prolonged atrial refractoriness, lesser degrees of conduction disturbance and a lower rate of atrial fibrillation induction seem to be predictive of stable sinus rhythm. In contrast, patients with persistence of atrial fibrillation despite pacing have a more abnormal and inhomogeneous atrial substrate, as well as a higher rate of atrial fibrillation induction.

Prolonged P wave, shortened refractoriness, or remarkably abnormal conduction disturbances in the presence of prolonged refractoriness limit the effectiveness of standard atrial pacing in atrial fibrillation prevention. Identification of predictive criteria of failure of single-site atrial pacing may be used to consider dual-site atrial pacing in such patients with sinus node dysfunction.

Key Words: Sinus node dysfunction, atrial fibrillation, electrophysiological study, atrial pacing


Correspondence: A. De Sisti, Centre Chirurgical Val D'Or, 16 rue Pasteur 92210, Saint-Cloud, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.